Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May -
June
- July - August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
- 2013 -
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
May 2013 - 37 products
IP
Cardiogen-82
PR
PR
k.A.
generatore di radionuclidi: Strontium (82-sr) la Calibrazione Data 3.3-5.6 G
Bracco Suisse SA
A
FB
G
IP
CI
PP
Dymista Nasenspray
17 ml
16.97
35.90
10 %
Viatris Pharma GmbH
B / SL / SO
FB
G
L
IP
CI
Quetiapin-Mepha retard 50 mg
60 Tablet(s)
30.51
51.50
10 %
Delayed release tablets: Quetiapinum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Quetiapin-Mepha retard 150 mg
60
58.38
83.50
10 %
Delayed release tablets: Quetiapinum 150 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Quetiapin-Mepha retard 150 mg
100
97.30
128.25
10 %
Delayed release tablets: Quetiapinum 150 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin-Mepha retard 200 mg
60 Tablet(s)
72.22
99.40
10 %
Delayed release tablets: Quetiapinum 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin-Mepha retard 200 mg
100 Tablet(s)
118.57
152.65
10 %
Delayed release tablets: Quetiapinum 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin-Mepha retard 300 mg
60 Tablet(s)
102.06
133.70
10 %
Delayed release tablets: Quetiapinum 300 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin-Mepha retard 300 mg
100 Tablet(s)
167.35
208.70
10 %
Delayed release tablets: Quetiapinum 300 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin-Mepha retard 400 mg
60 Tablet(s)
141.66
179.20
10 %
Delayed release tablets: Quetiapinum 400 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin-Mepha retard 400 mg
100 Tablet(s)
236.10
287.70
10 %
Delayed release tablets: Quetiapinum 400 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Valsartan Axapharm 80 mg
28 Tablet(s)
9.90
19.60
10 %
Coated tablets: Valsartanum 80 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan Axapharm 80 mg
98 Tablet(s)
32.01
53.20
10 %
Coated tablets: Valsartanum 80 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan Axapharm 160 mg
28 Tablet(s)
11.91
26.00
10 %
Coated tablets: Valsartanum 160 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan Axapharm 160 mg
98 Tablet(s)
42.11
64.80
10 %
Coated tablets: Valsartanum 160 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan HCT Axapharm
80/12.5 mg
28 Tablet(s)
9.55
19.20
10 %
Coated tablets: 2 Active Agents
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan HCT Axapharm
80/12.5 mg
98 Tablet(s)
30.87
51.90
10 %
Coated tablets: 2 Active Agents
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan HCT Axapharm
160/12.5 mg
28 Tablet(s)
11.33
25.35
10 %
Coated tablets: 2 Active Agents
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan HCT Axapharm
160/12.5 mg
98 Tablet(s)
39.63
61.95
10 %
Coated tablets: 2 Active Agents
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan HCT Axapharm
160/25 mg
28 Tablet(s)
11.33
25.35
10 %
Coated tablets: 2 Active Agents
axapharm ag
B / SL / SG
FB
G
IP
CI
Valsartan HCT Axapharm
160/25 mg
98 Tablet(s)
39.63
61.95
10 %
Coated tablets: 2 Active Agents
axapharm ag
B / SL / SG
FB
G
IP
CI
Bisoprolol-Mepha 2.5 mg
30 Tablet(s)
2.74
7.25
10 %
Tablets: Bisoprololi Fumaras 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bisoprolol-Mepha 2.5 mg
100 Tablet(s)
7.13
16.40
10 %
Tablets: Bisoprololi Fumaras 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bisoprolol-Mepha 5 mg
30 Tablet(s)
4.37
9.15
10 %
Tablets: Bisoprololi Fumaras 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bisoprolol-Mepha 5 mg
100 Tablet(s)
12.05
26.15
10 %
Tablets: Bisoprololi Fumaras 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bisoprolol-Mepha 10 mg
30 Tablet(s)
7.82
17.20
10 %
Tablets: Bisoprololi Fumaras 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bisoprolol-Mepha 10 mg
100 Tablet(s)
22.15
41.85
10 %
Tablets: Bisoprololi Fumaras 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
V/S
Cinryze 500 IE
2 x 500 / 0 UI
1382.03
1459.00
10 %
Lyophilisate and solvent: C1-esterasi Inhibitor Humanus 500 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Betesil
8 plaster(s)
16.40
35.25
10 %
Patch: Betamethasoni Valeras 2.25 mg
IBSA Institut
Biochimique SA
B / SL
FB
G
L
IP
CI
Betesil
16 plaster(s)
28.86
49.60
10 %
Patch: Betamethasoni Valeras 2.25 mg
IBSA Institut
Biochimique SA
B / SL
FB
G
L
IP
CI
PP
Erivedge
28 Capsule(s)
4882.26
5255.45
10 %
Capsules: Vismodegibum 150 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
PP
Kadcyla 100 mg
Durchstechflasche(n)
1495.37
1703.20
10 %
Pulver zur Herstellung eines Infusionslösungskonzentrates: Trastuzumabum Emtansinum 100 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
PP
Kadcyla 160 mg
Durchstechflasche(n)
2392.59
2688.20
10 %
Pulver zur Herstellung eines Infusionslösungskonzentrates: Trastuzumabum Emtansinum 160 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
SmofKabiven peripher 1206 ml
4 x 1206 ml
PR
PR
k.A.
Infusion emulsion: Glucosum
Infusion emulsion: 22 Active Agents
Infusion emulsion: 5 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven peripher 1448 ml
4 x 1448 ml
PR
PR
k.A.
Infusion emulsion: Glucosum
Infusion emulsion: 22 Active Agents
Infusion emulsion: 5 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
CI
Betesil
4 plaster(s)
PR
PR
k.A.
Patch: Betamethasoni Valeras 2.25 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Valsartan Axapharm 40 mg
28 Tablet(s)
PR
PR
k.A.
Coated tablets: Valsartanum 40 mg
axapharm ag
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home